Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature.
about
Cancer of the endometrium: current aspects of diagnostics and treatmentControversies in the management of endometrial cancer.Controversies in the management of endometrial carcinoma.Preserving fertility in young patients with endometrial cancer: current perspectives.Novel strategies for systemic treatment of endometrial cancer.Role of progesterone in endometrial cancerProgesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature.Endometrial adenocarcinoma in a 27-year-old woman.Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumorsProgestins and endometrial cancer.Vaginal treatment of endometrial cancer: role in the elderlyInfluence of AKT on progesterone action in endometrial diseases.Wnt/Β-catenin and sex hormone signaling in endometrial homeostasis and cancer.Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls.Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.Contemporary quality of life issues affecting gynecologic cancer survivors.Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma.Conserving fertility in the management of gynaecological cancers.Comparison among fertility-sparing therapies for well differentiate early-stage endometrial carcinoma and complex atypical hyperplasia.Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devicesA novel saline infusion sonohysterography-based strain imaging approach for evaluation of uterine abnormalities in vivo: preliminary resultsClinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancerSquamous morules are functionally inert elements of premalignant endometrial neoplasia.Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.Fertility sparing treatment in young patients with early endometrial adenocarcinoma: case series.Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometriumA successful live birth through in vitro fertilization program after conservative treatment of FIGO grade I endometrial cancer.Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option.Emerging drugs in endometrial cancers.Role of canonical Wnt signaling in endometrial carcinogenesis.A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer.Fertility outcomes of patients with early stage endometrial carcinoma.The effects of cancer therapy on women's fertility: what do we know now?Endometrial cancer: Not your grandmother's cancer.Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review.
P2860
Q24797130-77CAEC32-0F9F-4771-BE0A-D8D966A35523Q33960860-0CE6A3A0-EC40-4DD0-BD1F-04E87EB0FDA2Q33960894-ACB64BC7-F580-4809-ADAF-B850CF3CC6A4Q34005400-948F12BC-22DB-44A5-9813-EA782C6F921BQ34090973-AC34F003-A11D-4211-A682-5221ED2C847CQ34095034-ECBC6EEE-52CA-4972-8293-98FEC81C841AQ34147704-B11A060F-5F94-4E87-9BE6-65412A852FBDQ34321877-D12A45F9-9D8D-4B63-A33A-10726EFE54F2Q34353091-9BCAA75D-612D-4489-962E-E16408F4AA27Q34611371-9D0A21E9-291E-42B7-ABA7-F2FC5E5C04F9Q34656815-FB0CF752-4542-4B97-87B4-09D0B00BAD0DQ34847502-9523F528-A2FC-4931-A956-9E63F87AE154Q35181499-05A41AA4-B84E-4F24-A5A7-31FDF49136EBQ35617565-54098529-19C1-4823-AF79-FF53CEFA318BQ35640118-774C79F6-1EF3-4DA9-B1AD-ADD226C7F1A3Q35886066-799874F0-A690-49E9-AA1B-F2E3A45E3E63Q35945498-CDF7EC40-76A1-4D82-893B-E595C30C1322Q36067725-789FED1D-5F51-431F-9973-E1EA6311852DQ36075885-C60CC833-9CFF-4736-9FDA-CA118DE921DBQ36367795-3A46DD6F-A5A6-4E17-916A-FF958D390CEBQ36376499-E538662C-F37C-49BC-8ABC-C85E81971ADEQ36547575-9BA006F9-4EC4-4325-9BAD-A5698610C5B8Q36669005-6284CFCE-019B-41E4-BC22-7964E26A354CQ36860495-FF0BB13B-A1D9-4E78-9016-029740A29C49Q36905719-FB93EB51-1F47-4842-B26C-CC2FACC8C361Q37078918-E095186A-BB08-4794-8799-37D06515B836Q37199883-B929D8B5-C14F-47DA-B07E-CA1C623C4F78Q37257915-EFAFDE91-6635-4300-B93E-FABA8404603DQ37260863-97004277-ADC1-4710-B8A3-5DE34FBBF4F2Q37313394-4AA119A5-DFEE-43BD-937A-E4D56D1A43FAQ37512337-FD1D6FC0-596B-4550-AE9D-C51DEAC87AF4Q37534521-661E836F-308C-4F60-AAB5-3B9A1CEE18E2Q37786618-EA8A7A23-9EC0-4549-BD5E-467F9CB7541BQ37965633-9B8050B8-A038-45D7-AE4A-FCE428DEFEFCQ38037824-20B93F03-5F94-4440-B4D6-725B98E8E9BFQ38137243-B56B2BDE-9EF7-45DE-B9AD-BA8FB8A51A7EQ38765968-98895B37-2546-42F5-9E13-4EA71D499A22Q38852405-121D2D19-BD0F-4A4B-93D9-6695BFBF4A75Q40428249-3DE52948-904B-434A-BCBD-1D139DA219B4Q42090449-C96BC664-93A7-4229-9132-00950EA73749
P2860
Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Progestin alone as primary tre ...... and review of the literature.
@en
type
label
Progestin alone as primary tre ...... and review of the literature.
@en
prefLabel
Progestin alone as primary tre ...... and review of the literature.
@en
P2093
P2860
P1433
P1476
Progestin alone as primary tre ...... and review of the literature.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2
P407
P577
1997-01-01T00:00:00Z